| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,000 | 0,000 | 07.02. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 29.01. | Peptonic Medical AB announces outcome of the rights issue | 1 | Cision News | ||
| 29.01. | Peptonic Medical AB changes date for publication of year-end report | 4 | Cision News | ||
| 23.01. | PEPTONIC MEDICAL AB: Last day of trading with unit rights in Peptonic's rights issue | 1 | Cision News | ||
| 14.01. | PEPTONIC MEDICAL AB: The subscription period in Peptonic's rights issue of units starts today | 2 | Cision News | ||
| 13.01. | PEPTONIC MEDICAL AB: Peptonic publishes prospectus in connection with rights issue of units | 2 | Cision News | ||
| 07.01. | XFRA CAPITAL ADJUSTMENT INFORMATION - 07.01.2026 | 544 | Xetra Newsboard | Das Instrument SFTU US83404D1090 SOFTBANK GR.UNS.ADR1/2/ON EQUITY wird cum Kapitalmassnahme gehandelt am 07.01.2026 und ex Kapitalmassnahme am 08.01.2026 The instrument SFTU US83404D1090 SOFTBANK GR.UNS.ADR1/2/ON... ► Artikel lesen | |
| 06.01. | Spotlight Stock Market: Market Notice 1/26 - Information regarding the rights issue from Peptonic Medical AB | 1 | Cision News | ||
| 23.12.25 | Peptonic Medical AB. Corporate reconstruction formally concluded following dismissal decision | 1 | Cision News | ||
| PEPTONIC MEDICAL Aktie jetzt für 0€ handeln | |||||
| 23.12.25 | Peptonic Medical AB's Reconstruction plan becomes legally binding and the reconstruction is concluded | 1 | Cision News | ||
| 16.12.25 | Peptonic Medical AB clarifies expected conclusion of its corporate reconstruction | 2 | Cision News | ||
| 28.11.25 | Peptonic Medical AB's reconstruction plan approved by the Uppsala District Court | 1 | Cision News | ||
| 27.11.25 | Peptonic Medical AB: Plan Hearing Held at Uppsala District Court | 1 | Cision News | ||
| 27.11.25 | Peptonic Medical AB Presents Current Sales Figures | 1 | Cision News | ||
| 17.11.25 | Peptonic Medical AB (publ) - Corporate Restructuring Continues | 1 | Cision News | ||
| 30.10.25 | PEPTONIC MEDICAL AB: Peptonic Medical receives part of first order from Joylux worth USD 126,000 | 2 | Cision News | ||
| 27.10.25 | Date for the Plan Meeting in the Corporate Reorganization of Peptonic Medical AB (publ) Announced | 1 | Cision News | ||
| 23.10.25 | Reconstruction Plan in Peptonic Medical AB (publ)'s Corporate Restructuring Published | 2 | Cision News | ||
| 14.10.25 | PEPTONIC MEDICAL AB: Peptonic Medical signs strategic distribution agreement with Joylux Inc. for the USA, Canada, Mexico, and the UK | 2 | Cision News | ||
| 19.09.25 | PEPTONIC MEDICAL AB: Peptonic Medical: Uppsala District Court approves extension of corporate reconstruction | 2 | Cision News | ||
| 10.09.25 | PEPTONIC MEDICAL AB: Peptonic Medical requests extension of corporate reconstruction and provides update on financial performance | 1 | Cision News |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 41,400 | -2,82 % | HV-Termine: Hauptversammlungen bei Adv. Blockchain, Aurubis, Fortec, Schott, Siemens, Healthineers, Stabilus, TUI | Einmal jährlich müssen sich Aufsichtsrat und Vorstand einer Gesellschaft den Aktionären stellen: Die Hauptversammlung ist das höchste Organ einer Aktiengesellschaft und vergleichbarer Unternehmens-Formen.... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,640 | +0,40 % | Fresenius Medical Care: Ein Neuanfang nach turbulenten Zeiten? | ||
| FRESENIUS | 49,760 | +1,06 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Fresenius mit einem Kursziel von 55 Euro auf "Buy" belassen. Die Bad Homburger seien in Verjüngungskur, und der Markt preise... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 28,740 | +4,89 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 39,680 | +3,44 % | BrightSpring Health Services, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026 | ||
| CARL ZEISS MEDITEC | 27,520 | +0,66 % | BARCLAYS stuft CARL ZEISS MEDITEC AG auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Carl Zeiss Meditec von 49 auf 32 Euro gesenkt und die Aktien von "Overweight" auf "Equal Weight" abgestuft. Nur... ► Artikel lesen | |
| HEARTFLOW | 27,690 | +6,54 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| GENEDX | 84,35 | +0,32 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 21,990 | +2,23 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen | |
| GERRESHEIMER | 25,660 | +1,99 % | JEFFERIES stuft GERRESHEIMER AG auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Gerresheimer mit einem Kursziel von 34,10 Euro auf "Buy" belassen. Analyst James Vane-Tempest zählt den Spezialverpackungshersteller... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,750 | +2,84 % | 6 Analysts Have This To Say About Alignment Healthcare | ||
| PROGYNY | 21,960 | +0,18 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| HIMS & HERS HEALTH | 19,500 | +0,15 % | BREAKING: Hims & Hers verschärft Preisdruck bei Novo Nordisk - Aktie beschleunigt Talfahrt | Der dänische Biopharma-Riese ist erst seit wenigen Wochen mit seinem Appetitzügler Wegovy als Tablette auf dem US-Markt und sieht sich einem massiven Preisdruck ausgesetzt. Das Telehealth-Unternehmen... ► Artikel lesen | |
| UNITEDHEALTH | 232,15 | -0,77 % | UnitedHealth: Das sieht gar nicht gut aus | Der enttäuschende Ausblick, den UnitedHealth dem Kapitalmarkt vor Kurzem an die Hand gegeben hat, und maue Aussichten für 2027 hinterlassen weitere Spuren im Aktienkurs des größten US-Krankenversicherers.... ► Artikel lesen | |
| RXSIGHT | 8,390 | +7,29 % | RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer | ALISO VIEJO, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following... ► Artikel lesen |